Mr. Scovel is a seasoned sales executive and business leader with more than 30 years of experience in the dialysis and renal care space. He has dedicated the majority of his career to advancing innovative dialysis technologies, with deep expertise in both home dialysis and critical care therapies. Curt is widely recognized for his ability to translate clinical value into commercial success, driving adoption of solutions that improve outcomes for patients with kidney failure.
Prior to joining Sonavex, Curt served as Vice President of Sales at Quanta Dialysis Technologies and spent over a decade as Vice President of Sales and Clinical at NxStage Medical. There, he led a national team of more than 80 sales, clinical, and education professionals focused on expanding access to home dialysis. He played a key role in growing the patient base from early-stage adoption to over 13,000 patients and more than $300 million in revenue, while helping position NxStage for its $2 billion acquisition by Fresenius Medical Care. Earlier in his career, Curt was instrumental in launching and scaling Continuous Renal Replacement Therapy (CRRT) solutions, including converting one of the largest programs in the country.
Curt’s leadership style centers on empowerment, collaboration, and accountability. He is passionate about developing high-performing teams and driving innovation that expands access to life-changing dialysis therapies.